Post-Transcriptional HIV-1 Latency: A Promising Target for Therapy?
Viruses,
Journal Year:
2024,
Volume and Issue:
16(5), P. 666 - 666
Published: April 24, 2024
Human
Immunodeficiency
Virus
type
1
(HIV-1)
latency
represents
a
significant
hurdle
in
finding
cure
for
HIV-1
infections,
despite
tireless
research
efforts.
This
challenge
is
partly
attributed
to
the
intricate
nature
of
latency,
wherein
various
host
and
viral
factors
participate
multiple
physiological
processes.
While
substantial
progress
has
been
made
discovering
therapeutic
targets
transcription,
post-transcriptional
regulation
infections
have
received
less
attention.
However,
cumulative
evidence
now
suggests
pivotal
contribution
both
vitro
models
infected
individuals.
In
this
review,
we
explore
recent
insights
on
discuss
potential
its
targets,
illustrating
some
that
restrict
at
level.
Language: Английский
Integrated Genetic and Cellular Analysis Reveals NLRP1 Activation in CD4+ T Lymphocytes During Chronic HIV Infection
Immunological Investigations,
Journal Year:
2024,
Volume and Issue:
unknown, P. 1 - 20
Published: Nov. 4, 2024
Background
Most
of
the
investigations
related
to
inflammasome
activation
during
HIV
infection
have
focused
on
receptor
NLRP3
and
innate
immune
cells
such
as
monocytes/macrophages.
However,
past
years,
has
also
been
explored
in
lymphocytes,
novel
sensors,
other
than
NLRP3,
shown
play
a
role
biology
these
cells.
Here,
we
hypothesized
that
NLRP1
may
be
involved
CD4+
T
cell
dysregulation
people
living
with
(PLWH),
therefore
contributing
chronic
inflammation
pathogenesis
non-HIV-associated
diseases.
Language: Английский
HIV-SEQ REVEALS GLOBAL HOST GENE EXPRESSION DIFFERENCES BETWEEN HIV-TRANSCRIBING CELLS FROM VIREMIC AND SUPPRESSED PEOPLE WITH HIV
bioRxiv (Cold Spring Harbor Laboratory),
Journal Year:
2024,
Volume and Issue:
unknown
Published: Dec. 20, 2024
Abstract
“Active”
reservoir
cells
transcribing
HIV
can
perpetuate
chronic
inflammation
in
virally
suppressed
people
with
(PWH)
and
likely
contribute
to
viral
rebound
after
antiretroviral
therapy
(ART)
interruption,
so
they
represent
an
important
target
for
new
therapies.
These
cells,
however,
are
difficult
study
using
single-cell
RNA-seq
(scRNA-seq)
due
their
low
frequency
levels
of
transcripts,
which
usually
not
polyadenylated.
Here,
we
developed
“HIV-seq”
enable
more
efficient
capture
transcripts
–
including
non-polyadenylated
ones
scRNA-seq
analysis
from
PWH.
By
spiking
a
set
custom-designed
sequences
targeting
conserved
regions
the
genome
during
scRNA-seq,
increased
our
ability
find
RNA+
PWH
by
up
44%.
Implementing
HIV-seq
conjunction
surface
phenotyping
CITE-seq
on
paired
blood
specimens
before
vs.
ART
suppression,
found
that
were
enriched
among
T
effector
memory
(Tem)
both
viremia
but
exhibited
cytotoxic
signature
only.
contrast,
ART-suppressed
timepoints
distinct
anti-inflammatory
involving
elevated
TGF-β
diminished
IFN
signaling.
Overall,
these
findings
demonstrate
active
exhibit
transcriptional
features
viremia,
underscore
as
useful
tool
better
understand
mechanisms
HIV-transcribing
persist
ART.
Language: Английский